nat gas up huge this morning and a divi paying trust that has the ability to pay over 16.00 in distributions over it's life ...
something is seriously a miss here
as long as we remain under the radar I'll be a buyer!
a new product?
AmbioDry2®, the MiMedx PURION® Processed single layer amnion, contains four to five times greater amounts of growth factors than the competitive single layer amnion products (DryFlex®, AmnioExCel®, SteriShield™, and SteriShield II™) that were evaluated in the study.
Trust does not terminate till 2030 and nat gas prices rising going into fall/winter
Even if the trust continues to pay what resembles the last distribution I calculate close to 16.00 in dividends until termination
that's a great payday!
Candyclown... the strength in MDXG PPS over the past week confirms your on borrowed time.
how_bout...enlighten us all
"on October 21, 2013, OSIR stated that it reached an agreement with the FDA on September 30, 2013. Part of that agreement includes that OSIR will have to file a Biologics License Application in order to obtain the drug’s approval from the FDA. "
Gee .... wonder when they plan to submit? What's the hold up?
Could not have happened to a nicer bunch of folks
No shocker since the 10Q outlined they are having to go back and "check the books"
Many big players can't invest with companies that have these sort of questionable accounting issues. I bet the big buys on MDXG and the big sells last week for OSIR were attributed to the market voting which company is going to come out on top. IMO
IMO they are trusting the advice of these fancy "Harvard Ivy League" types for there information. I don't blame them for trying to impress management and try to add value but it's clear we have some sell side hedgies and chartists that are playing games with the stock. I'd add and still believe there is a competitor connection. The team at OSIR is "in the know" of those with very deep pockets.
Back in the "pink sheet" days, I recall, there were cockroaches then ... and bet they never went away IMHO
As further described in our Annual Report on Form 10-K for our fiscal year ended December 31, 2013, as filed with the Securities and Exchange Commission on March 31, 2014, our management determined that our processes, procedures and controls related to financial reporting were not effective to ensure effective oversight of the work performed by, and the accuracy of financial information or professional conclusions provided by, third-party tax advisors, regarding components of the income tax provision calculation (specifically the allocation between continuing and discontinuing operations), given a one-time significant transaction of disposing of a business segment. This occurred notwithstanding that we had retained a nationally known outside public accounting firm, which we understand to be PCAOB certified, to advise us on, and to analyze and to perform the tax accounting functions related to, these matters. This material weakness was identified in connection with our assessment of the effectiveness of internal control over financial reporting as of December 31, 2013, and as of June 30, 2014 had not determined to have been remediated..
Notwithstanding the identified material weakness described above, management believes that the financial statements and other financial information included in this report present fairly in all material respects our financial condition, results of operations and cash flows at and for the periods presented in accordance with accounting principles generally accepted in the United States.With the oversight of our management and the audit committee of our board of directors, we have since taken steps and plan to take additional measures to remediate the underlying causes of the material weakness described above. Because the identified material weakness has not yet been remediated, however, this control deficiency could result in a material misstatement of the financial statements that would not be prevented or detected. See the risk factor in our 2013 Form 10-K contained in Part I, Item 1A under the heading “Risk Factors—We have identified a material weakness in our internal control over financial reporting and we may be unable to develop, implement and maintain appropriate controls in future periods. If the material weakness is not remediated, then it could result in a material misstatement to the financial statements.”
help me out here doc .... you said:
ETFs borrowing shares from an account and they do a lot of buy/sell
This is what they said? To me, sounds like we have a hedge fund or two correct?
That was an odd come back, but then again they are not finance guys.
candya@# ... you're a real friggin joke! (although I'm stating the obvious)
Petit has said on past conference call THE COMPANY WILL BE SOLD ... BUY BUY BUY
and you will FRY FRY FRY